David Chang
NEW ORLEANS — Current preoperative and intraoperative technologies are enabling better toric IOL implantation outcomes, but the potential FDA approval of a new type of lens may change the procedure, according to a speaker here.
“We have all these great technologies right now. They’re giving us better results than we’ve ever gotten, but if we did get adjustable lenses, all of a sudden most of this becomes superfluous because we’re just going to actually treat the refraction at the end,” David F. Chang, MD, said at Cornea Subspecialty (Read more...)
Uncategorized